Cologne, 10 September 2024 –
Ningaloo proudly unveiled the MLA-1 today, an innovative laboratory device designed for controlling cultured cells with light, through a technology called optogenetics. This state-of-the-art system brings several advanced features that significantly enhance research capabilities and streamline laboratory workflows.
The MLA-1 is equipped with wireless connectivity through Bluetooth technology, allowing researchers to operate the device remotely and integrate it seamlessly into modern lab environments. It offers a high dynamic range of light intensities, ensuring precise control and adaptability to a wide variety of experimental needs. To minimize variability and improve accuracy, the MLA-1 comes pre-calibrated, ensuring consistency in light intensities across different wells. With interchangeable light guides, the MLA-1 can be effortlessly adapted for use with 6, 24, and 96-well formats, offering flexibility for various experimental setups. Additionally, the device features an intuitive software, which makes it easy to use for researchers of all levels of experience and supports electronic documentation.
Dr. Hanns-Martin Schmidt, co-founder and head of R&D, emphasized:
“The MLA-1 was developed in close collaboration with renowned laboratories and tested extensively. We’ve already gathered promising biological data using state-of the art optogenetic systems as well as our proprietary photoswitch systems. I am extremely proud of the team and the work they have done to bring this innovative product to market.”
Dr. Herbert Müller-Hartmann, co-founder of Ningaloo, added:
“We recently presented the MLA-1 to an excited audience at the 4th Optogenetic Technologies and Applications Conference in Boston, MA. This is only the beginning of our mission to provide the bioproduction industry with a scalable platform that leverages our technology to enable the sustainable production of novel therapeutics for millions of patients. Major pharmaceutical companies and contract development and manufacturing organizations (CDMOs) have already shown interest in our technology, and we are continuously working with them to address the current challenges in bioproduction.”
With its innovative design and robust features, the MLA-1 is set to revolutionize optogenetic research and process development, offering scientists a versatile and reliable tool for achieving greater precision and efficiency in their applications.